Vectura 
Welcome,         Profile    Billing    Logout  
 14 Products   223 Diseases   14 Products   9 Trials   2094 News 


«12345678910111213...1617»
  • ||||||||||  Triglide (fenofibrate) / Vectura, Shionogi
    Journal:  Modification of the zeta potential of montmorillonite to achieve high active pharmaceutical ingredient nanoparticle loading and stabilization with optimum dissolution properties. (Pubmed Central) -  Apr 7, 2021   
    When examined together, the data for all six APIs suggest a general trend whereby API nanoparticles with zeta potentials more positive than around -25 mV do not require carrier particle surface modification with PA in order to preserve their fast dissolution rates from NP-carrier composites at higher API loadings. Thus, this study offers a potentially effective means of transforming poorly water soluble BCS Class II APIs into fast dissolving solid dosage NP-carrier composites, whereby the surface properties of the carrier particle can be tuned with prior knowledge of the zeta potential of the API nanoparticles.
  • ||||||||||  Triglide (fenofibrate) / Vectura, Shionogi
    Review, Journal:  Evidence and indications for systemic treatment in diabetic retinopathy: a systematic review. (Pubmed Central) -  Apr 1, 2021   
    Systemic intervention appears important in different stages of DR. While IGC seems effective in relation to incident and progressive DR, antihypertensive treatments may be valuable in the early stages of DR, as opposed to fenofibrate, which could benefit at a later stage.
  • ||||||||||  Triglide (fenofibrate) / Vectura, Shionogi
    [VIRTUAL] Bone Breaking Triglycerides () -  Mar 27, 2021 - Abstract #ENDO2021ENDO_3225;    
    For oral presentations, the abstracts are embargoed until the session begins. The Endocrine Society reserves the right to lift the embargo on specific abstracts that are selected for promotion prior to or during ENDO 2021.
  • ||||||||||  Triglide (fenofibrate) / Vectura, Shionogi
    [VIRTUAL] Hypertriglyceridemia-Induced Pancreatitis () -  Mar 27, 2021 - Abstract #ENDO2021ENDO_3222;    
    For oral presentations, the abstracts are embargoed until the session begins. The Endocrine Society reserves the right to lift the embargo on specific abstracts that are selected for promotion prior to or during ENDO 2021.
  • ||||||||||  Triglide (fenofibrate) / Vectura, Shionogi
    [VIRTUAL] Statin Intolerance: Prevalence and Management in a Specialized Lipid Clinic () -  Mar 27, 2021 - Abstract #ENDO2021ENDO_3210;    
    Fenofibrate was associated with significantly less frequent adverse effects than statins (p=0.006)...For oral presentations, the abstracts are embargoed until the session begins. The Endocrine Society reserves the right to lift the embargo on specific abstracts that are selected for promotion prior to or during ENDO 2021.
  • ||||||||||  Triglide (fenofibrate) / Vectura, Shionogi
    Journal:  Severe L-asparaginase-induced Hypertriglyceridaemia Treated with Plasmapheresis. (Pubmed Central) -  Mar 27, 2021   
    This response illustrates the strong effectiveness of early treatment with plasmapheresis in severe and symptomatic hypertriglyceridaemia associated with L-asparaginase. Pancreatitis following L-asparaginase-induced hypertriglyceridaemia is a severe and potentially reversible condition in both adults and children treated for acute lymphoblastic leukaemia.Early plasmapheresis is more effective to rapidly decrease serum triglycerides.
  • ||||||||||  Triglide (fenofibrate) / Vectura, Shionogi
    Journal:  Shared PPARα/γ Target Genes Regulate Brown Adipocyte Thermogenic Function. (Pubmed Central) -  Mar 25, 2021   
    Among these, we focused on the lysosomal protease cathepsin Z (CTSZ) and showed it is necessary for mitochondrial respiration in both mouse and human brown adipocytes. Thus, CTSZ is a shared PPARα/γ target gene in BAT and a regulator of brown adipocyte thermogenic function.
  • ||||||||||  Triglide (fenofibrate) / Vectura, Shionogi
    Clinical, Journal:  Fenofibrate decreased microalbuminuria in the type 2 diabetes patients with hypertriglyceridemia. (Pubmed Central) -  Mar 25, 2021   
    P4
    Thus, CTSZ is a shared PPARα/γ target gene in BAT and a regulator of brown adipocyte thermogenic function. In the patients with hypertriglyceridemia and type 2 diabetes mellitus, fenofibrate can improve microalbuminuria and do not increase the deterioration of glomerular filtration rate.
  • ||||||||||  Triglide (fenofibrate) / Vectura, Shionogi
    Clinical, Journal, Real-world evidence:  No Time to Waste: Real-World Repurposing of Generic Drugs as a Multifaceted Strategy Against COVID-19. (Pubmed Central) -  Mar 17, 2021   
    Having previously fast-tracked this paper to publication in summary form, we now expand on why cimetidine/famotidine (histamine type-2 receptor antagonists), dipyridamole (antiplatelet agent), fenofibrate/bezafibrate (cholesterol/triglyceride-lowering agents), and sildenafil (phosphodiesterase-5 inhibitor) are worth considering for patients with COVID-19 based on their antiviral, anti-inflammatory, renoprotective, cardioprotective, and anticoagulation properties. These examples also reveal the unlimited opportunity to future-proof public health by proactively mining, synthesizing, and cataloging the off-label treatment opportunities of thousands of safe, well-established, and affordable generic drugs.
  • ||||||||||  Seebri Breezhaler (glycopyrronium bromide) / Novartis, Vectura, Sosei
    Journal:  Muscarinic inhibition of salivary glands with glycopyrronium bromide does not reduce the uptake of PSMA-ligands or radioiodine. (Pubmed Central) -  Mar 13, 2021   
    In the IRIDIUM trial, the changes from baseline in evening plasma cortisol level at Week 52 were generally comparable across all treatment arms. Muscarinic inhibition of salivation with GPB did not significantly reduce the uptake of PSMA-ligands or radioiodine in salivary glands, and can be dismissed as a potential strategy to reduce toxicity from radionuclide therapies.
  • ||||||||||  Triglide (fenofibrate) / Vectura, Shionogi
    Preclinical, Journal:  Effects of low and high doses of fenofibrate on protein, amino acid, and energy metabolism in rat. (Pubmed Central) -  Feb 24, 2021   
    HFFD causes signs of hepatotoxicity, impairs energy and protein balance in muscles, and decreases BCAA, methionine, and lysine. It is suggested that increased glycine and decreased lysine and methionine levels are due to activated carnitine synthesis; decreased BCAA and BCKA levels are due to increased BCAA oxidation.
  • ||||||||||  micronized fenofibrate / Generic mfg., fenofibrate / Generic mfg.
    Biomarker, Trial completion, Enrollment change, Trial completion date, Trial primary completion date:  Fenofibrate in Type 2 Diabetes (clinicaltrials.gov) -  Feb 23, 2021   
    P4,  N=11, Completed, 
    It is suggested that increased glycine and decreased lysine and methionine levels are due to activated carnitine synthesis; decreased BCAA and BCKA levels are due to increased BCAA oxidation. Recruiting --> Completed | N=40 --> 11 | Trial completion date: Mar 2021 --> Mar 2020 | Trial primary completion date: Dec 2020 --> Mar 2020
  • ||||||||||  Flutiform (fluticasone/formoterol) / Kyorin, Mundipharma, Vectura, Sanofi, Alvesco (ciclesonide) / Covis Pharma, Teijin, Korea University Medical Center
    Clinical, Journal:  Use of Assist Devices to Actuate Pressurized Metered-Dose Inhalers in Elderly Patients with Asthma. (Pubmed Central) -  Feb 7, 2021   
    Furthermore, the study suggests the utmost importance of developing a standardized model of metabolic syndrome in place of the great diversity between available models, which can induce different effects and negatively impact the validity of prospective studies. Finger muscle strength should be considered when selecting a device for older patients with asthma, and the use of a pMDI assist device to push the canister is recommended in patients with weaker finger muscles.
  • ||||||||||  Triglide (fenofibrate) / Vectura, Shionogi
    Journal:  Transfer of Lipophilic Drugs from Nanoemulsions into Lipid-Containing Alginate Microspheres. (Pubmed Central) -  Feb 3, 2021   
    Lipophilicity, estimated according to the calculated logP value of the respective drug, was a major factor influencing the transfer performance: the higher the logP value, the slower the transfer. This experimental setup is a promising technique to investigate the release of poorly water-soluble drugs from various types of nanocarriers under closer to physiological conditions than with many other methods currently applied.
  • ||||||||||  Triglide (fenofibrate) / Vectura, Shionogi
    [VIRTUAL] The Troublesome Triad: Hypertriglyceridemia-Induced Acute Pancreatitis in Diabetic Ketoacidosis (On-Demand) -  Feb 2, 2021 - Abstract #ENDO2021ENDO_1077;    
    CT abdomen showed hepatic steatosis andperipancreatic inflammation, confirming the diagnosis.Hewas admitted to the ICU, received aggressive IV fluid resuscitation with 5%dextrose in half normal saline while on an insulin infusion, with morphine andondansetron to control his pain and nausea...He was transitioned to an oraldiet with subcutaneous insulin prior to discharge on insulin and fenofibrate.At 1 month follow up, he reported medication compliance and denied anyrecurrence. Conclusion :While DKA rarely triggers HTGAP in 1000 mg/dL is required for diagnosis of HTGAP, and thedegree of elevation is associated with the severity of pancreatitis.
  • ||||||||||  Triglide (fenofibrate) / Vectura, Shionogi
    [VIRTUAL] Challenges in Managing Metabolic Complications in a Patient With Familial Partial Lipodystrophy Type 3 (On-Demand) -  Feb 2, 2021 - Abstract #ENDO2021ENDO_1016;    
    She also was found to have Polycystic Ovarian Syndrome (PCOS) based on menstrual irregularities, hirsutism and ultrasound showing multiple ovarian cysts, and was treated with spironolactone...Often these are not sufficient in addressing the complexity of metabolic derangements in these patients who have an increased risk of cardiovascular events at a young age. Further research about agents targeting this gene in particular would be beneficial.
  • ||||||||||  Triglide (fenofibrate) / Vectura, Shionogi
    [VIRTUAL] Metabolic Improvements After Gastric Sleeve Surgery in a Patient With Familial Partial Lipodystrophy (On-Demand) -  Feb 2, 2021 - Abstract #ENDO2021ENDO_619;    
    Despite aggressive therapy with dietary changes, fenofibrate, statin, omega-3, and niacin, he had multiple episodes of pancreatitis with TG levels >5000 mg/dl on many occasions...He has not required plasmapheresis for over a year so far and his TG levels are consistently <500 mg/dl while only on rosuvastatin 40 mg, with the most recent TG level of 182 mg/dl...For oral presentations, the abstracts are embargoed until the session begins. The Endocrine Society reserves the right to lift the embargo on specific abstracts that are selected for promotion prior to or during ENDO 2021.
  • ||||||||||  Triglide (fenofibrate) / Vectura, Shionogi
    Journal:  Cholesterotropic and cuprotropic chemicals. (Pubmed Central) -  Jan 29, 2021   
    TRIAL REGISTRATION: ClinicalTrials.gov, (Identifier: NCT03063086), EudraCT start date: May 11, 2017; First patient first visit / study initiation date: May 31, 2017. No abstract available
  • ||||||||||  Triglide (fenofibrate) / Vectura, Shionogi
    Journal:  Fenofibrate Protects Cardiomyocytes from Hypoxia/Reperfusion- and High Glucose-Induced Detrimental Effects. (Pubmed Central) -  Jan 29, 2021   
    Endothelial nitric oxide synthase was also favored in cardiomyocytes treated with fenofibrate. Our results suggest that fenofibrate preserves the antioxidant status and the ultrastructure in cardiomyocytes undergoing HG, H/R, and HG+H/R preventing damage to essential macromolecules involved in the proper functioning of the cardiomyocyte.